Renaissance Technologies
IDIX

Renaissance Technologies’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Renaissance Technologies’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-16,466
Closed -$59K – 3094
2013
Q2 		$59K Buy
+16,466
New +$67.3K ﹤0.01% 2681

Other funds holding IDIX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies's IDIX Position: Q3 2013 in Review

Renaissance Technologies sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2013, closing a stake of 16,466 shares — an estimated $59K sold.

Renaissance Technologies first reported a position in IDIX in Q2 2013 and held it in 1 quarter. The position peaked at $59K in Q2 2013. 93 funds tracked by Wall St. Rank hold IDIX as of Q3 2013.

  • Renaissance Technologies reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Renaissance Technologies sold 16,466 IDENIX PHARMACEUTICALS INC shares in Q3 2013, an estimated $59K.
  • Renaissance Technologies first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Renaissance Technologies's IDENIX PHARMACEUTICALS INC position peaked at $59K in Q2 2013.
  • 93 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2013.

Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.